# Carglumic acid

NDC: 68475-006
Generic name: Carglumic acid
Labeler / Manufacturer: Navinta LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FOR SUSPENSION
Routes: ORAL
Marketing started: 20220801

FDA application: ANDA213395

## Active ingredients

- CARGLUMIC ACID: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68475-006"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68475-006
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=59e73eb8-edf8-4fad-93c2-deb6b23497f8